The U.S. Food and Drug Administration (FDA) is asking Januvia and Janumet's drugmaker to add information about the risk of pancreatitis to the medications' labels.
Submitted by Darron
Avandia Raises Heart Failure Risk More Than Actos
Diabetes drug shouldn't be used when there's a safer alternative, study says
By Steven Reinberg
HealthDay Report..
TUESDAY, Aug. 18 (HealthDay News) -- The type 2 diabetes drug Avandia (rosiglitazone) increases the risk of heart failure and death more than another drug in the same class, Actos (pioglitazone), new Canadian research contends.
Avandia has been the subject of controversy since 2007, when it was linked... read more
Submitted by jigsaw
State-by-state report finds too few people meet fruit and veggie guidelines
Type 1 DiabetesBasics
Treatment
Management
Caregiving
Type 1 Diabetes: Tracking Blood Sugar Levels
For people with type 1 diabetes, tracking blood sugar levels is a critical daily habit.
By Madeline Vann, MPH
Medically reviewed by Pat F. Bass III, MD, MPH Print Email
If you have type 1 diabetes, then what you eat, how much you exercise, and how you take your... read more
Submitted by jigsaw
Type 2 DiabetesBasics
Diagnosis
Prevention
Treatment
Management
Caregiving
Causes of Type 2 Diabetes
Eating too much and exercising too little are two of the main reasons why people develop type 2 diabetes.
By Madeline Vann, MPH
Medically reviewed by Christine Wilmsen Craig, MD Print Email Insulin is a hormone made in the pancreas that allows glucose (sugar) to leave... read more
Submitted by jigsaw
Biocon Ltd., India’s biggest biotechnology company, plans to begin commercial production of an insulin pill within 18 months, giving millions of diabetes sufferers a new way of controlling blood-sugar.
The orally administered hormone is in the final of three stages of patient studies that drugs usually require for regulatory approval, Biocon Managing Director Kiran Mazumdar- Shaw said in an interview in Kuala Lumpur today.
If successful, the tablet would help the Bangalore-based... read more
Submitted by Avera
Much attention has focused on the increasing prevalence of childhood type 2 diabetes mellitus. However, considerable evidence suggests that the incidence of childhood type 1 diabetes mellitus is also increasing. The results of a multicenter registration study from Europe confirm this alarming trend, which has important health-care implications.
Submitted by Avera
Sanofi Aventis (SASY.PA) on Tuesday launched a research plan to probe the safety of insulin, including its Lantus diabetis drug.
The research program is designed to generate more information on whether there is any association between cancer and insulin use and to assess if there is any difference in risk between insulin glargine -- such as Lantus -- and other insulins.
Sanofi-Aventis said its scientific programme and studies will be initiated in the coming weeks.... read more
Submitted by Avera
Insulin may help turn back the clock on elderly muscle loss, U.S. researchers said.
Submitted by Amy Tenderich
MONDAY, Sept. 28 -- Patients who take the diabetes drugs known as thiazolidinediones may be at higher risk of bone fracture, new research suggests.
In the study, Dr. Ian Douglas of the London School of Hygiene and Tropical Medicine and colleagues searched a database of more than 6 million patients in the United Kingdom and found 1,819 people aged 40 and older who had had a bone fracture and had been prescribed a type of... read more
Submitted by Gabby